Checkpoint NOW

Afreen Shariff
  • 5.0 (1)
  • MEDICINE
  • UPDATED BIWEEKLY

All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.

  1. JUN 5

    Episode 31: Journal Club: To re-challenge or not in refractory pneumonitis

    Host Dr. Afreen Shariff is joined by guest host Dr. Pankti Reid, Rheumatologist, University of Chicago where they discuss the topic "To re-challenge or not in refractory pneumonitis" with expert Pulmonologist Dr. Kevin Ho (The Ohio State University) and Medical Oncologist Dr. Aliyah Pabani (Johns Hopkins Medicine) who discuss some key articles. Articles: https://pmc.ncbi.nlm.nih.gov/articles/PMC7797270/Balaji, et al, J Immunother Cancer. 2021 https://pubmed.ncbi.nlm.nih.gov/33568350/ Beattie, et al, J Immunother Cancer. 2021

    38 min

  2. MAY 9

    Episode 30: Fatigue and Cancer- Symptom of cancer or a sign of a toxicity?

    Join hosts Dr. Afreen Shariff (Duke, Citrus Oncology) and Dr. Pauline Funchain (Stanford) as they discuss a common yet challenging topic of fatigue in a cancer patient with guest expert, medical oncologist, palliative care expert, ASCO guideline lead Dr. Eric Roeland (Oregon Health).

    42 min

  3. 2024-11-12

    Episode 29: Balancing conversations about toxicities

    Join hosts Drs. Afreen Shariff and Pauline Funchain as they discuss with health care communications expert Dr. Timothy Gilligan from Cleveland Clinic about the delicate balance between the fear of toxicities and providing meaningful information for patients and caregivers so they feel empowered and engaged.

    54 min

  4. 2024-10-07

    Episode 28: Alliance Clinical Trial for Immune Mediated toxicities

    Join hosts Dr. Afreen Shariff and Dr. Pauline Funchain as they discuss with Dr. David Kozono, a radiation oncologist at Dana Farber Cancer Institute and the chair of the ALLIANCE clinical trial to set up a national Biorepository to Study Immunotherapy Side Effects. https://www.allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml?path=/Public/News-A151804-Oct2020

    21 min

  5. 2024-08-19

    Episode 27: ASPirE- The International Alliance for Support and Prevention of immune related Events

    Join the Executive Committee of ASPirE- Dr. Afreen Shariff, Dr. Pauline Funchain, Dr. Kerry Reynolds, Dr. Alexa Meara and Dr. Elad Sharon as they discuss the new international Initiative that brings clinicians, educators, researchers and patients together to inform science and clinical innovation in irAEs.

    52 min

  6. 2024-08-13

    Episode 26: Cancer treatments and the Heart

    Learn about the effect of cancer treatments on the heart. Who needs to see a cardiologist before, during and after cancer treatment- the When and Why with oncologist Dr. Susan Dent and cardio oncologist Dr. Robert Copeland-Halperin.

    45 min

  7. 2024-07-07

    Episode 25: Adrenal Insufficiency- What patients need to know.

    Join Dr. Afreen Shariff and Dr. Pauline Funchain as they break down Adrenal Insufficiency from cancer treatments in simple terms for patients, caregivers and care teams.

    47 min

  8. 2023-10-23

    Episode 24: Costs of adverse events in Renal Cell Carcinoma

    Learn from the experts about the costs associated with irAEs in patients treated for Renal Cell Carcinoma. Join our hosts Dr. Afreen Shariff and Dr. Tian Zhang as they discuss with guest experts- medical Oncologists Dr. Daniel Geynisman and Dr. Bradley McGregor, MD for an informative and high yield discussion regarding real and hidden costs of adverse events and how this impacts patients.

    25 min
See All (32)

Trailer

About

All you need to know about the latest evidence based practice in the diagnosis and management of immune related toxicities from cancer therapies straight from the experts in the field.

Information

  • Creator
    Afreen Shariff
  • Years Active
    2020 - 2025
  • Episodes
    32
  • Rating
    Clean
  • Copyright
    © Afreen Shariff
  • Show Website
    Checkpoint NOW